Issue: March, 2021

Read more

January 24, 2021
1 min read
Save

Miami Cancer Institute appoints deputy director

Issue: March, 2021
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Manmeet Ahluwalia, MD, FACP, MBA, has been appointed deputy director of Baptist Health’s Miami Cancer Institute.

Ahluwalia — a neuro-oncologist whose research focuses on primary brain tumors and brain metastases — also will serve as chief scientific officer and chief of solid tumor medical oncology.

“We are confident that the innovation that he will bring to our clinical trials efforts will benefit our patients and enhance the reputation of our institute,” Leonard Kalman, MD, executive deputy director and chief medical officer at Miami Cancer Institute, said in a press release.

Manmeet Ahluwalia, MD, FACP, MBA
Manmeet Ahluwalia

Ahluwalia — a HemOnc Today Editorial Board member — previously served as Dean and Diane Miller family endowed chair in neuro-oncology and head of operations in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center at Cleveland Clinic. He also served as a professor in the department of medicine at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.